Source: BIOPORTFOLIO

Exelan Pharmaceuticals: Cipla Injects Scale With $550m US Buy

This is the second such buyout deal involving an Indian firm in the US after Lupin snapped up the privately owned niche firm Gavis Pharmaceuticals LLC and Novel Laboratories for $880m in July.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
$1.2M
Est. Employees
10
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more